Literature DB >> 20361728

Phosphorylation of the transcription factor Ets-1 by ERK2: rapid dissociation of ADP and phospho-Ets-1.

Kari Callaway1, William F Waas, Mark A Rainey, Pengyu Ren, Kevin N Dalby.   

Abstract

ERK2, a major effector of the BRAF oncogene, is a promiscuous protein kinase that has a strong preference for phosphorylating substrates on Ser-Pro or Thr-Pro motifs. As part of a program to understand the fundamental basis for ERK2 substrate recognition and catalysis, we have studied the mechanism by which ERK2 phosphorylates the transcription factor Ets-1 at Thr-38. A feature of the mechanism in the forward direction is a partially rate-limiting product release step (koff = 59 +/- 6 s(-1)), which is significant because to approach maximum efficiency substrates for ERK2 may evolve to ensure that ADP dissociation is rate-limiting. To improve our understanding of the mechanism of product release, the binding of the products to ERK2 was assessed and the reaction was examined in the reverse direction. These studies demonstrated that phospho-Ets-1 (p-Ets) binds >20-fold more tightly to ERK2 than ADP (Kd = 7.3 and 165 microM, respectively) and revealed that the products exhibit little interaction energetically while bound to ERK2 and that they can dissociate ERK2 in a random order. The overall equilibrium for the reaction in solution (Keq = 250 M(-1)) was found to be similar to that with the substrate bound to the enzyme (Kint = 525 M(-1)). To determine what limits koff, several pre-steady-state experiments were performed. A catalytic trapping approach furnished a rate constant (k-ADPa) of 61 +/- 12 s(-1) for the dissociation of ADP from the abortive ternary complex, ERK2.Ets.ADP. To examine p-Ets dissociation, the binding of a fluorescent derivative (p-Ets-F), which binds ERK2 with an affinity similar to that of p-Ets, was examined by stopped-flow kinetics. Using this approach, p-Ets-F was found to bind through a single-step mechanism, with the following parameters: k-p-Ets-F = 121 +/- 3.8 s(-1), and kp-Ets-F = (9.4 +/- 0.3) X 10(6) M(-1) s(-1). Similar results were found in the presence of a saturating ADP concentration. These data suggest that koff may be limited by the dissociation of both products and are consistent with the notion that Ets-1 has evolved to be an efficient substrate for ERK2, where ADP release is, at least, partially rate-limiting. A molecular mechanics model of the complex formed between ERK2 and residues 28-138 of Ets-1 provides insight into the role of substrate docking interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361728      PMCID: PMC2868174          DOI: 10.1021/bi100199q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Nucleotide release and associated conformational changes regulate function in the COOH-terminal Src kinase, Csk.

Authors:  J Shaffer; G Sun; J A Adams
Journal:  Biochemistry       Date:  2001-09-18       Impact factor: 3.162

2.  Purification of a model substrate for transcription factor phosphorylation by ERK2.

Authors:  W F Waas; K N Dalby
Journal:  Protein Expr Purif       Date:  2001-10       Impact factor: 1.650

Review 3.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

4.  A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.

Authors:  Jialin Zhang; Bo Zhou; Chao-feng Zheng; Zhong-yin Zhang
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

Review 5.  Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs.

Authors:  Michiaki Kohno; Jacques Pouyssegur
Journal:  Prog Cell Cycle Res       Date:  2003

6.  Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.

Authors:  Fred L Robinson; Angelique W Whitehurst; Malavika Raman; Melanie H Cobb
Journal:  J Biol Chem       Date:  2002-01-31       Impact factor: 5.157

7.  Transient protein-protein interactions and a random-ordered kinetic mechanism for the phosphorylation of a transcription factor by extracellular-regulated protein kinase 2.

Authors:  William F Waas; Kevin N Dalby
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

Review 8.  Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.

Authors:  Ricardo M Biondi; Angel R Nebreda
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

9.  Two rate-limiting steps in the kinetic mechanism of the serine/threonine specific protein kinase ERK2: a case of fast phosphorylation followed by fast product release.

Authors:  William F Waas; Mark A Rainey; Anna E Szafranska; Kevin N Dalby
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  14 in total

1.  Examining docking interactions on ERK2 with modular peptide substrates.

Authors:  Sunbae Lee; Mangalika Warthaka; Chunli Yan; Tamer S Kaoud; Pengyu Ren; Kevin N Dalby
Journal:  Biochemistry       Date:  2011-10-18       Impact factor: 3.162

2.  In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression.

Authors:  Diana Zamora-Olivares; Tamer S Kaoud; Kevin N Dalby; Eric V Anslyn
Journal:  J Am Chem Soc       Date:  2013-09-18       Impact factor: 15.419

Review 3.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.

Authors:  Andrea Piserchio; Mangalika Warthaka; Tamer S Kaoud; Kari Callaway; Kevin N Dalby; Ranajeet Ghose
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

6.  Solution NMR insights into docking interactions involving inactive ERK2.

Authors:  Andrea Piserchio; Mangalika Warthaka; Ashwini K Devkota; Tamer S Kaoud; Sunbae Lee; Olga Abramczyk; Pengyu Ren; Kevin N Dalby; Ranajeet Ghose
Journal:  Biochemistry       Date:  2011-04-19       Impact factor: 3.162

7.  The PNT domain from Drosophila pointed-P2 contains a dynamic N-terminal helix preceded by a disordered phosphoacceptor sequence.

Authors:  Desmond K W Lau; Mark Okon; Lawrence P McIntosh
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

8.  Applying the brakes to multisite SR protein phosphorylation: substrate-induced effects on the splicing kinase SRPK1.

Authors:  Brandon E Aubol; Joseph A Adams
Journal:  Biochemistry       Date:  2011-07-15       Impact factor: 3.162

Review 9.  Genomic and biochemical insights into the specificity of ETS transcription factors.

Authors:  Peter C Hollenhorst; Lawrence P McIntosh; Barbara J Graves
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

10.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.